PTGS2 and colorectal carcinoma: Among the 18 studies evaluating COX-2 overexpression of OS of CRC, 9 studies (1093 patients, 27.8%) were performed in Asian populations, and the remaining 9 studies (2841 patients, 72.2%) followed non-Asian patients.